Latest from prostate cancer
Researchers from SWOG Cancer Research Network have significantly extended median survival for patients with hormone-sensitive metastatic prostate cancer. This result comes from a large randomized clinical trial aimed at testing a new treatment for these patients.
Researchers at Imperial College London, University College London and Imperial College Healthcare NHS Trust have found that a new type of ultrasound scan can diagnose most prostate cancer cases with good accuracy in a clinical trial involving 370 men.
- Men are at a higher risk of developing certain health conditions as compared to women, from heart diseases to diabetes. Here are certain health checkups they should undergo after consultation with their doctor.
An experimental prostate cancer drug improved the survival of hospitalised Covid-19 patients in Brazil in a clinical trial, researchers reported. Benefits were similar across genders, even though women might not be expected to respond to drugs that block male hormones
Men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease, suggest the findings of a new study.